Together, our data suggest that PIK3R4 functions as a novel regulator of immune cell infiltration within the DLBCL tumour microenvironment and is a valuable potential prognostic biomarker for DLBCL patients. Here, PIK3R4 is linked to diffuse large B-cell lymphoma.